(Q70880353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

0 references

1 reference

title

Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

W H Frishman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

R Gabor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

C Pepine

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

E Cavusoglu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

language of work or name

English

0 references

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

204-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

Coronary artery occlusion in the conscious dog. Effects of alterations in heart rate and arterial pressure on the degree of myocardial ischemia

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Heart rate reduction--a mechanism of benefit?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Pathophysiology of angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Influence of heart rate on mortality after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

The use of β-adrenergic blocking drugs in patients with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Prognostic significance of electrocardiographic site of infarction after correction for enzymatic size of infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Beneficial effects of vagal stimulation on the ischaemic myocardium during beta-receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Haemodynamic and metabolic effects of timolol (Blocadren) on ischaemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Alinidine, a new agent which lowers heart rate in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Muscarinic modulation of cardiac rate at low acetylcholine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Slow inward current and its role mediating the chronotropic effect of epinephrine in the rabbit sinoatrial node

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

On the mechanism of the ?specific bradycardic action? of the verapamil derivative UL-FS 49

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Specific bradycardic agents--a novel pharmacological class?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

ULFS-49 Causes Bradycardia Without Decreasing Right Ventricular Systolic and Diastolic Performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Effect of zatebradine on contractility, relaxation and coronary blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Influence of the force-frequency relation on left ventricular function during exercise in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Effect of tachycardia on regional function and transmural myocardial perfusion during graded coronary pressure reduction in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Effects of AQ-AH 208, a new specific bradycardic agent, on myocardial ischemia-reperfusion injury in anesthetized dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

Central α-adrenergic systems as targets for hypotensive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990075-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(96)90075-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8554014%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference